RAPT Therapeutics, Inc. (RAPT)

NASDAQ: RAPT · Real-Time Price · USD

57.74

-0.03 (-0.05%)

At close: Feb 10, 2026, 4:00 PM EST

57.70

-0.04 (-0.07%)

After-hours: Feb 10, 2026, 5:12 PM EST

RAPT Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,785	213	855	672	1,085	485
Market Cap Growth	1021.17%	-75.05%	27.19%	-38.08%	123.77%	-19.54%
Enterprise Value	1,631	120	677	484	874	362
Last Close Price	57.74	12.64	198.80	158.40	293.84	158.00
PS Ratio	-	-	-	440.09	284.61	96.19
PB Ratio	6.40	1.12	5.81	2.74	5.82	4.66
P/TBV Ratio	11.75	1.12	5.81	2.74	5.82	4.66
EV/Sales Ratio	-	-	-	317.25	229.33	71.83
Debt / Equity Ratio	0.02	0.02	0.05	0.04	-	-
Asset Turnover	-	-	-	0.01	0.02	0.05
Quick Ratio	11.76	4.78	7.28	17.51	19.77	9.50
Current Ratio	12.04	4.87	7.41	17.77	20.11	9.85
Return on Equity (ROE)	-85.37%	-77.09%	-59.56%	-38.86%	-47.63%	-59.66%
Return on Assets (ROA)	-51.35%	-41.13%	-36.13%	-23.07%	-27.24%	-32.67%
Return on Capital Employed (ROCE)	-73.90%	-70.90%	-83.90%	-34.00%	-36.60%	-49.60%
Earnings Yield	-5.92%	-60.90%	-13.66%	-12.48%	-6.38%	-10.91%
FCF Yield	-4.85%	-39.12%	-11.49%	-10.66%	-5.69%	-8.43%
Buyback Yield / Dilution	-347.95%	-6.32%	-17.82%	-18.80%	-13.49%	-455.27%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q